Services

BostonGene supports precision medicine trial design and analytics of biomarker-driven clinical trials.

BostonGene’s integrated multi-omics data analysis identifies novel multi-parameter biomarkers of therapy response or resistance that are associated with tumor genomics, transcriptomics and the microenvironment.

BostonGene provides DNA and RNA sequencing, histology, tissue imaging and flow cytometry in a CLIA-certified environment.

BostonGene increases therapeutic efficacy and minimizes clinical trial failures by assisting with patient selection via integrated molecular profiling.

BostonGene identifies multi-parameter biomarkers and molecular signatures of response that can then be developed into companion diagnostics.

BostonGene uses a combination of multiple technologies such sequencing, imaging, proteomics, and cytometry to validate research findings to ensure scientific integrity.

BostonGene is continuously adjusting current sequencing technologies and developing novel technologies to improve our research capabilities.

BostonGene performs validation and hypothesis testing on uniformly processed and annotated cohorts of RNA / DNA sequenced tissues and microarrays consisting of thousands of patients.

BostonGene’s cloud-based computational platform is designed to provide parallel calculations of multi-omics data from various sources to robustly and rapidly analyze data.

BostonGene seamlessly integrates DNA/RNA sequencing, methylation sequencing, scRNA-seq, histology, tissue imaging, and flow cytometry data.

BostonGene can identify novel drug targets utilizing uniformly processed and annotated cohorts of sequenced tissues and microarrays consisting of thousands of patients.

Large clinical datasets uncover new biomarkers and validate clinical hypotheses.

BostonGene supports personalized vaccine clinical trials through vaccine design, which is based on mutated oncogenic peptides, fusions and splice site-derived expressed neoantigens.

BostonGene provides support in publication writing and encourages joint publications of scientific findings and analyses.

BostonGene assists in clinical trial design using synergistic combinations of targeted and immunotherapies.

BostonGene utilizes machine learning methods to create computational models of therapy response prediction.